Recent Advances in Inflammation & Allergy Drug Discovery

ISSN: 2772-2708• JCR: RECENT ADV INFLAMM ANetherlands
1.1
2025 Impact Factor
1.3
5-Year Impact Factor
Q4
JCR Quartile
N/A
CAS Block

Recent Advances in Inflammation & Allergy Drug Discovery impact factor and JCR quartile

The 2025 impact factor for Recent Advances in Inflammation & Allergy Drug Discovery is 1.1. The 5-year impact factor is 1.3. The journal is listed as JCR Q4 in the current Journal Metrics dataset.

Use this record to check the journal title, ISSN, JCR quartile, CAS block, publisher details, and similar journals before comparing publication venues.

If you searched for Recent Advances in Inflammation & Allergy Drug Discovery impact factor 2025, compare this exact title record with the journal homepage and nearby journals in the same field. That helps avoid mixing this journal with a similarly named title, abbreviation, society series, or outdated metric snippet.

2025 impact factor and source check

This page is designed for exact-title searches such as Recent Advances in Inflammation & Allergy Drug Discovery impact factor 2025. First confirm that the ISSN and title match this record before using the metric in a journal shortlist or submission decision.

For high-stakes submission decisions, verify the title against the publisher record, Clarivate's Master Journal List or Journal Citation Reports if you have access, and the context in our methodology. Treat the 5-year impact factor, JCR quartile, article volume, and similar journals as supporting context rather than a single-number publication decision.

Article Volume

2021
5
2022
36
2023
21
2024
43
2025
26
2026
5
Back to Search